Quarterly report · Q1

Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥9.9bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Revenue¥36.5bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥7.6bn2021-04-01 → 2021-06-30Cons.Revenue IFRS
Operating income¥897m2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income¥647m2021-04-01 → 2021-06-30Cons.Operating profit loss IFRS
Profit before tax¥910m2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax¥3.7bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥648m2021-04-01 → 2021-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥502m2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥2.4bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥428m2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥628m2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Net income¥2.6bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥451m2021-04-01 → 2021-06-30Cons.Profit loss IFRS
Total assets¥54.3bnat 2022-06-30Cons.Assets IFRS
Total assets¥52.5bnat 2022-03-31Cons.Assets IFRS
Total assets¥41.1bnat 2021-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥33.1bnat 2022-06-30Cons.Liabilities IFRS
Total liabilities¥32.3bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥21.2bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥20.2bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥16.3bnat 2021-06-30Cons.Equity IFRS
Net assets / equity¥16.4bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥16.8bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥17.0bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥14.8bnat 2021-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥19.7bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥18.2bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥14.4bnat 2021-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥14.6bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥2.1bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥5.3bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥664m2021-04-01 → 2021-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥679m2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥196m2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥112m2021-04-01 → 2021-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥126m2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥2.0bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥742m2021-04-01 → 2021-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥12.592022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥59.652021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥10.762021-04-01 → 2021-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥12.552022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥59.462021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥10.732021-04-01 → 2021-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio31.0%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio32.4%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio35.9%at 2021-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥98m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥98m
jpcrp040300-q1r_E05463-000Application Servicereportable segmentrevenue2022-04-01 → 2022-06-30¥1.6bn
jpcrp040300-q1r_E05463-000Application Servicereportable segmentrevenue external2022-04-01 → 2022-06-30¥1.6bn
jpcrp040300-q1r_E05463-000Application Servicereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥37m
jpcrp040300-q1r_E05463-000Application Servicereportable segmentsegment profit2022-04-01 → 2022-06-30−¥65m
jpcrp040300-q1r_E05463-000Information Infrastructurereportable segmentrevenue2022-04-01 → 2022-06-30¥6.3bn
jpcrp040300-q1r_E05463-000Information Infrastructurereportable segmentrevenue external2022-04-01 → 2022-06-30¥6.3bn
jpcrp040300-q1r_E05463-000Information Infrastructurereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥59m
jpcrp040300-q1r_E05463-000Information Infrastructurereportable segmentsegment profit2022-04-01 → 2022-06-30¥590m
jpcrp040300-q1r_E05463-000Medical System Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥2.0bn
jpcrp040300-q1r_E05463-000Medical System Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥2.0bn
jpcrp040300-q1r_E05463-000Medical System Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥2m
jpcrp040300-q1r_E05463-000Medical System Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥372m
—segment totalrevenue2022-04-01 → 2022-06-30¥10.0bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥9.9bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥98m
—segment totalsegment profit2022-04-01 → 2022-06-30¥897m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥108m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥108m
jpcrp040300-q1r_E05463-000Application Servicereportable segmentrevenue2021-04-01 → 2021-06-30¥1.6bn
jpcrp040300-q1r_E05463-000Application Servicereportable segmentrevenue external2021-04-01 → 2021-06-30¥1.6bn
jpcrp040300-q1r_E05463-000Application Servicereportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥16m
jpcrp040300-q1r_E05463-000Application Servicereportable segmentsegment profit2021-04-01 → 2021-06-30−¥54m
jpcrp040300-q1r_E05463-000Information Infrastructurereportable segmentrevenue2021-04-01 → 2021-06-30¥5.4bn
jpcrp040300-q1r_E05463-000Information Infrastructurereportable segmentrevenue external2021-04-01 → 2021-06-30¥5.3bn
jpcrp040300-q1r_E05463-000Information Infrastructurereportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥84m
jpcrp040300-q1r_E05463-000Information Infrastructurereportable segmentsegment profit2021-04-01 → 2021-06-30¥592m
jpcrp040300-q1r_E05463-000Medical System Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥747m
jpcrp040300-q1r_E05463-000Medical System Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥740m
jpcrp040300-q1r_E05463-000Medical System Businessreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥7m
jpcrp040300-q1r_E05463-000Medical System Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥110m
—segment totalrevenue2021-04-01 → 2021-06-30¥7.7bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥7.6bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥108m
—segment totalsegment profit2021-04-01 → 2021-06-30¥647m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 669
ItemContextValueUnit
Equity IFRSPrior1YearInstant20202276000JPY
Equity IFRSCurrentQuarterInstant21155520000JPY
Liabilities and equity IFRSPrior1YearInstant52503713000JPY
Liabilities and equity IFRSCurrentQuarterInstant54286836000JPY
Revenue IFRSPrior1YTDDuration7612950000JPY
Revenue IFRSCurrentYTDDuration9883710000JPY
Cost of sales IFRSPrior1YTDDuration5010286000JPY
Cost of sales IFRSCurrentYTDDuration6411798000JPY
Gross profit IFRSPrior1YTDDuration2602664000JPY
Gross profit IFRSCurrentYTDDuration3471912000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration1955312000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration2594990000JPY
Other income IFRSPrior1YTDDuration785000JPY
Other income IFRSCurrentYTDDuration43302000JPY
Other expenses IFRSPrior1YTDDuration729000JPY
Other expenses IFRSCurrentYTDDuration23014000JPY
Operating profit loss IFRSPrior1YTDDuration647408000JPY
Operating profit loss IFRSCurrentYTDDuration897209000JPY
Finance income IFRSPrior1YTDDuration4484000JPY
Finance income IFRSCurrentYTDDuration29816000JPY
Finance costs IFRSPrior1YTDDuration3552000JPY
Finance costs IFRSCurrentYTDDuration13544000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration-JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration-3939000JPY
Profit loss before tax IFRSPrior1YTDDuration648341000JPY
Profit loss before tax IFRSCurrentYTDDuration909541000JPY
Income tax expense IFRSPrior1YTDDuration197449000JPY
Income tax expense IFRSCurrentYTDDuration281262000JPY
Profit loss IFRSPrior1YTDDuration450891000JPY
Profit loss IFRSCurrentYTDDuration628278000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration427631000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration502401000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration23260000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration125877000JPY
Basic earnings loss per share IFRSPrior1YTDDuration10.76
Basic earnings loss per share IFRSCurrentYTDDuration12.59
Diluted earnings loss per share IFRSPrior1YTDDuration10.73
Diluted earnings loss per share IFRSCurrentYTDDuration12.55
Profit loss IFRSPrior1YTDDuration450891000JPY
Profit loss IFRSCurrentYTDDuration628278000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration-32244000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration50100000JPY
Total of items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration-32244000JPY
Total of items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration50100000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration3000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration50658000JPY
Total of items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration3000JPY
Total of items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration50658000JPY
Other comprehensive income IFRSPrior1YTDDuration-32241000JPY
Other comprehensive income IFRSCurrentYTDDuration100759000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass